06Aug
CBD is Everywhere - But Where Does the FDA Stand?
Seyfarth Synopsis: CBD is “thriving” in the current regulatory environment, but is it doing so illegally? As former U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb opined last week, “the CBD craze is getting out of hand. The...
By:
Seyfarth Shaw LLP
Related
The Federal Trade Commission (“FTC”) has announced the annual revisions to the Hart-Scott-Rodino A...
Read More >
The Ballard Spahr Zoning and Land Use Team is continuing to monitor all aspects of the Philadelphia ...
Read More >
Under Connecticut law, the “Safe Harbor” provision of C.G.S. § 31-294c (b) has widely been interp...
Read More >
The SEC has adopted amendments to the financial disclosure requirements in Regulation S-X for acquis...
Read More >
Sunday’s release of a long-awaited Labor Department final rule on joint employment spells trouble f...
Read More >
On 7 October 2019, the Council of the European Union formally adopted a new Directive on the protect...
Read More >